179 ( 28 % ) of 632 patients allocated dopamine agonists and 104 ( 23 % ) of 460 patients allocated MAOBI discontinued allocated treatment because of side-effects compared with 11 ( 2 % ) of 528 patients allocated levodopa ( p < 00001 ) .